In the future, improved understanding of the impact of ECD structure and its interaction with ligands and targeting Abs on PTPRS activity will be key to developing new strategies to modify the activity of R2A PTPs for the study and management of RA and other pathologies affected by this class of enzymes. The gene discussed is PTS; the disease is rheumatoid arthritis.